Interested in a 90% shorter needle?
Here are a few little pointers.

Find Fluzone Vaccines Near You

Find Fluzone Vaccine in your area

Search by Practice or Pharmacy

Search by practice or pharmacy (optional)

Find it now

Ask your health care provider about
Fluzone Intradermal vaccine or find it
at these participating pharmacies:

Learn About Other Fluzone Vaccines


Questions

  • Do you have questions about Fluzone Intradermal vaccine?

    Get answers

There's a Fluzone vaccine for you.

How is Fluzone Intradermal vaccine different from the flu shot I received last year?

The microneedle only goes as deep as the skin's surface.1,2 It contains less vaccine than the traditional flu shot (0.1mL compared to 0.5mL) and is designed to help protect you against the flu.1,3

Where is the microneedle injected?

Fluzone Intradermal vaccine is given in your upper arm — the same spot you were given your flu shot from last year.1,3

How small is the microneedle?

Fluzone Intradermal vaccine is the first FDAa-approved intradermal flu vaccine in the United States.4 The ultra-thin tip is only 1.5mm long; that's the same thickness of a US penny!2,5

What reaction, if any, can I expect from Fluzone Intradermal vaccine?

The most common side effects are redness, swelling, or a raised bump where the vaccine was injected.1 This is because the vaccination is given just under the skin.6 Other side effects include pain and itching.1 These reactions typically are not serious and generally resolve on their own within a few days.4

Is Fluzone Intradermal vaccine for everyone?

Fluzone Intradermal vaccine is approved only for adults 18-64 years of age.1 However, other flu vaccines are available for patients 6 months of age and older.

How much does Fluzone Intradermal vaccine cost?

Flu vaccines are typically covered by most insurance companies.7 For more information on your specific influenza vaccine coverage, please contact your insurance company.

Where can I get Fluzone Intradermal vaccine?

To find the vaccine in a location closest to you, use the Fluzone Locator.

a FDA = Food and Drug Administration.

Important Safety Information

Indication

Fluzone Intradermal vaccine is an inactivated influenza virus vaccine given to people 18 through 64 years of age for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

Safety Information

Redness, firmness, swelling, and itching at the injection site occur more frequently with Fluzone Intradermal vaccine than with Fluzone vaccine. Other common side effects to Fluzone Intradermal vaccine include pain, headache, fatigue, and muscle aches. Side effects other than those listed above may occur. Fluzone Intradermal vaccine should not be administered to anyone with a severe allergic reaction to any vaccine component, including eggs, egg products, or to a previous dose of any influenza vaccine. Tell the doctor if you have ever experienced Guillain-Barré syndrome (severe muscle weakness) after a previous dose of influenza vaccine. If you notice any other problems or symptoms following vaccination, please contact your health care professional immediately. Vaccination with Fluzone Intradermal vaccine may not protect all individuals.

For more information about Fluzone vaccine, talk to your health care professional and see complete Patient Information.

References

  1. Fluzone Intradermal vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.; 2012.
  2. Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine. 2008;26(26):3197-3208.
  3. Fluzone vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.; 2012.
  4. Icardi G, Orsi A, Ceravolo A, Ansaldi F. Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system. Hum Vaccin Immunother. 2012;8(1):67-75.
  5. US Mint. Coin specifications. http://www.usmint.gov/about_the_mint/?action=coin_specifications&pf.
  6. Reygrobellet C, Viala-Danten M, Meunier J, Weber F, Nguyen VH. Perception and acceptance of intradermal influenza vaccination: patient reported outcomes from phase 3 clinical trials. Hum Vaccin. 2010;6(4):336-345.
  7. DHHS. 2010 National Vaccine Plan. Washington, DC: US Department of Health and Human Services; 2010.

PLEASE NOTE

By clicking on this link, you will be leaving this Sanofi Pasteur website and going to another, entirely independent website. Sanofi Pasteur provides this link as a service to its website visitors; however, it takes no responsibility for the information presented on any website but its own.

This link has opened in a new window. To return to your original site, please close this new window.

Click here to go to the page you requested. Click here to close this window and return to the site.